A Phase 3 Study Comparing an Ointment Containing Calcipotriol 25 mcg/g Plus Hydrocortisone 10 mg g With Tacalcitol 4 mcg/g Ointment and the Ointment Vehicle Alone, All Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and on the Intertriginous Areas

Trial Profile

A Phase 3 Study Comparing an Ointment Containing Calcipotriol 25 mcg/g Plus Hydrocortisone 10 mg g With Tacalcitol 4 mcg/g Ointment and the Ointment Vehicle Alone, All Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and on the Intertriginous Areas

Completed
Phase of Trial: Phase III

Latest Information Update: 04 May 2015

At a glance

  • Drugs Calcipotriol/hydrocortisone (Primary) ; Tacalcitol
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 04 Jul 2012 Primary outcome added as reported by European Clinical Trials Database record.
    • 04 Jul 2012 Crookes Healthcare added as associations as reported in the European Clinical Trials Database record.
    • 25 Dec 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top